Proteomics identifies a marker signature of MAPKi resistance in melanoma. Proteomics identifies a marker signature of MAPKi resistance in melanoma
收藏NIAID Data Ecosystem2026-04-18 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA529368
下载链接
链接失效反馈官方服务：
资源简介：
Combined proteomic and RNAseq analysis on 6 melanoma cell cultures reveals a signature for resistance to MAPKi resistance. Overall design: 2 sensitive and 4 resistant melanoma cell cultures were RNAseqed
创建时间：
2019-03-27
